Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8397)
All Articles published online
|
Publishing Process of This Article
|
Oct 27, 2018 (publication date) through Nov 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Udomsinprasert W, Honsawek S, Poovorawan Y. Adiponectin as a novel biomarker for liver fibrosis. World J Hepatol 2018; 10(10): 708-718 [PMID: 30386464 DOI: 10.4254/wjh.v10.i10.708] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v10/i10/708.htm |
| Number | Citing Articles |
| 1 |
Manal Sabry Mohamed, Tarek Mohammed Youssef, Esraa Ebrahim Abdullah, Ahmed Elmetwally Ahmed. Correlation between adiponectin level and the degree of fibrosis in patients with non-alcoholic fatty liver disease. Egyptian Liver Journal 2021; 11(1) doi: 10.1186/s43066-021-00134-3
|
| 2 |
Alexandros Marios Sofias, Federica De Lorenzi, Quim Peña, Armin Azadkhah Shalmani, Mihael Vucur, Jiong-Wei Wang, Fabian Kiessling, Yang Shi, Lorena Consolino, Gert Storm, Twan Lammers. Therapeutic and diagnostic targeting of fibrosis in metabolic, proliferative and viral disorders. Advanced Drug Delivery Reviews 2021; 175: 113831 doi: 10.1016/j.addr.2021.113831
|
| 3 |
Sandra Maria Barbalho, Nahum Méndez-Sánchez, Lucas Fornari Laurindo. AdipoRon and ADP355, adiponectin receptor agonists, in Metabolic-associated Fatty Liver Disease (MAFLD) and Nonalcoholic Steatohepatitis (NASH): A systematic review. Biochemical Pharmacology 2023; 218: 115871 doi: 10.1016/j.bcp.2023.115871
|
| 4 |
Koen C. van Son, A.G. (Onno) Holleboom, Maarten E. Tushuizen. Visceral and Ectopic Fat. 2023; : 83 doi: 10.1016/B978-0-12-822186-0.00024-9
|
| 5 |
Eunyoung Lee, Hannelie Korf, Antonio Vidal-Puig. An adipocentric perspective on the development and progression of non-alcoholic fatty liver disease. Journal of Hepatology 2023; 78(5): 1048 doi: 10.1016/j.jhep.2023.01.024
|
| 6 |
Ayodeji Folorunsho Ajayi, Moyinoluwa Comfort Onaolapo, Ayomide Isaac Omole, Wale Johnson Adeyemi, David Tolulope Oluwole. Mechanism associated with changes in male reproductive functions during ageing process. Experimental Gerontology 2023; 179: 112232 doi: 10.1016/j.exger.2023.112232
|
| 7 |
Wen-Ze Xiao, Li Zhang. Adiponectin receptor agonist AdipoRon relieves endotoxin-induced acute hepatitis in mice. Chinese Medical Journal 2019; 132(20): 2438 doi: 10.1097/CM9.0000000000000488
|
| 8 |
Salvatore Pezzino, Tonia Luca, Mariacarla Castorina, Stefano Puleo, Saverio Latteri, Sergio Castorina. Role of Perturbated Hemostasis in MASLD and Its Correlation with Adipokines. Life 2024; 14(1): 93 doi: 10.3390/life14010093
|
| 9 |
Karina Gonzalez-Aldaco, Luis A. Torres-Reyes, Claudia Ojeda-Granados, Leonardo Leal-Mercado, Sonia Roman, Arturo Panduro. Metabolic Dysfunction-Associated Steatotic Liver Disease in Chronic Hepatitis C Virus Infection: From Basics to Clinical and Nutritional Management. Clinics and Practice 2024; 14(6): 2542 doi: 10.3390/clinpract14060200
|
| 10 |
Ou Wu, Xi Lu, Jianhang Leng, Xingyu Zhang, Wei Liu, Fenfang Yang, Hu Zhang, Jiajia Li, Saber Khederzadeh, Xiaodong Liu, Chengda Yuan. Reevaluating Adiponectin’s impact on obesity hypertension: a Chinese case-control study. BMC Cardiovascular Disorders 2024; 24(1) doi: 10.1186/s12872-024-03865-4
|
| 11 |
Nahid Karamzad, Vahid Maleki, Kristin Carson‐Chahhoud, Samaneh Azizi, Amirhossein Sahebkar, Bahram Pourghassem Gargari. A systematic review on the mechanisms of vitamin K effects on the complications of diabetes and pre‐diabetes. BioFactors 2020; 46(1): 21 doi: 10.1002/biof.1569
|
| 12 |
Anna Egresi, Anna Blázovics, Gabriella Lengyel, Adrienn Gréta Tóth, Barbara Csongrády, Zsuzsanna Jakab, Krisztina Hagymási. Redox Homeostasis and Non-Invasive Assessment of Significant Liver Fibrosis by Shear Wave Elastography. Diagnostics 2024; 14(17): 1945 doi: 10.3390/diagnostics14171945
|
| 13 |
Pnina Fishman, Shira Cohen, Inbal Itzhak, Johnny Amer, Ahmad Salhab, Faina Barer, Rifaat Safadi. The A3 adenosine receptor agonist, namodenoson, ameliorates non‑alcoholic steatohepatitis in mice. International Journal of Molecular Medicine 2019; doi: 10.3892/ijmm.2019.4364
|
| 14 |
Dennis D. Black. Impact of Bariatric Surgery on Adipose Tissue and Liver Inflammation in Adolescents with Nonalcoholic Steatohepatitis. The Journal of Pediatrics 2020; 216: 7 doi: 10.1016/j.jpeds.2019.08.063
|
| 15 |
Bertha Araceli Marin-Alejandre, Itziar Abete, Irene Cantero, J. Ignacio Monreal, Mariana Elorz, José Ignacio Herrero, Alberto Benito-Boillos, Jorge Quiroga, Ana Martinez-Echeverria, Juan Isidro Uriz-Otano, María Pilar Huarte-Muniesa, Josep A. Tur, J. Alfredo Martinez, M. Angeles Zulet. The Metabolic and Hepatic Impact of Two Personalized Dietary Strategies in Subjects with Obesity and Nonalcoholic Fatty Liver Disease: The Fatty Liver in Obesity (FLiO) Randomized Controlled Trial. Nutrients 2019; 11(10): 2543 doi: 10.3390/nu11102543
|
| 16 |
Nashi K. Alqahtani, Hisham A. Mohamed, Mahmoud E. Moawad, Nancy S. Younis, Maged E. Mohamed. The Hepatoprotective Effect of Two Date Palm Fruit Cultivars’ Extracts: Green Optimization of the Extraction Process. Foods 2023; 12(6): 1229 doi: 10.3390/foods12061229
|
| 17 |
Vahid Maleki, Reza Mahdavi, Fatemeh Hajizadeh-Sharafabad, Mohammad Alizadeh. A Comprehensive Insight into Potential Roles of Taurine on Metabolic Variables in Type 2 Diabetes: A Systematic Review. Pharmaceutical Sciences 2020; 26(3): 225 doi: 10.34172/PS.2020.17
|
| 18 |
Yoshiaki Yamanaka, Takafumi Tajima, Yoshitaka Tsujimura, Toichiro Naito, Yosuke Mano, Manabu Tsukamoto, Yukichi Zenke, Akinori Sakai. Adiponectin inhibits fibrosis of the palmar aponeurosis in Dupuytren’s contracture in male patients. Bone & Joint Research 2023; 12(8): 486 doi: 10.1302/2046-3758.128.BJR-2022-0449.R1
|
| 19 |
Lijun Xie, Huiying Wang, Jinying Hu, Zhuoying Liu, Fang Hu. The role of novel adipokines and adipose-derived extracellular vesicles (ADEVs): Connections and interactions in liver diseases. Biochemical Pharmacology 2024; 222: 116104 doi: 10.1016/j.bcp.2024.116104
|
| 20 |
Huan Jing, Simin Tang, Sen Lin, Meijuan Liao, Hongtao Chen, Youling Fan, Jun Zhou. Adiponectin in renal fibrosis. Aging 2020; 12(5): 4660 doi: 10.18632/aging.102811
|
| 21 |
Yahang Wang, Yuanyuan Li, Hua zhang, Leilei Zhu, Jie Zhong, Jiakai Zeng, Cong Meng, Jiasheng Wu, Tianming Wang, Rong Shi, Weian Yuan, Jian Jiang, Ping Liu, Yueming Ma. Pharmacokinetics-based comprehensive strategy to identify multiple effective components in Huangqi decoction against liver fibrosis. Phytomedicine 2021; 84: 153513 doi: 10.1016/j.phymed.2021.153513
|
| 22 |
Nerma Čustović, Senija Rašić. Relationship of serum adiponectin and resistin levels with the severity of liver fibrosis in patients with chronic hepatitis B. Journal of Medical Biochemistry 2022; 41(2): 176 doi: 10.5937/jomb0-33793
|
| 23 |
Wanvisa Udomsinprasert. Interleukin-1 family cytokines in liver cell death: a new therapeutic target for liver diseases. Expert Opinion on Therapeutic Targets 2023; 27(11): 1125 doi: 10.1080/14728222.2023.2285763
|
| 24 |
Dan Zhao, Xiaoyu Zhu, Lili Jiang, Xiu Huang, Yangyang Zhang, Xuejiao Wei, Xiaoxia Zhao, Yujun Du. Advances in understanding the role of adiponectin in renal fibrosis. Nephrology 2021; 26(2): 197 doi: 10.1111/nep.13808
|
| 25 |
Yong-Qing Zhao, Yi-Fan Ren, Bing-Bing Li, Chao Wei, Bin Yu. The mysterious association between adiponectin and endometriosis. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1396616
|
| 26 |
Laszlo Otvos. Potential Adiponectin Receptor Response Modifier Therapeutics. Frontiers in Endocrinology 2019; 10 doi: 10.3389/fendo.2019.00539
|
| 27 |
Naoki Shibata, Takanori Ito, Hidenori Toyoda, Akihito Tanaka, Yasuhiro Morita, Yasunori Kanzaki, Naoki Watanabe, Naoki Yoshioka, Satoshi Yasuda, Itsuro Morishima. Predictability of noninvasive liver fibrosis score for cardiac events in patients with nonalcoholic fatty liver disease. Nutrition, Metabolism and Cardiovascular Diseases 2024; 34(9): 2115 doi: 10.1016/j.numecd.2024.03.025
|
| 28 |
Tohfa Kabir, Haruki Yoshiba, Afifah Zahra Agista, Halima Sultana, Yusuke Ohsaki, Chiu-Li Yeh, Ryota Hirakawa, Hiroko Tani, Tomoki Ikuta, Tomonori Nochi, Suh-Ching Yang, Hitoshi Shirakawa. Protective Effects of Gnetin C from Melinjo Seed Extract against High-Fat Diet-Induced Hepatic Steatosis and Liver Fibrosis in NAFLD Mice Model. Nutrients 2023; 15(18): 3888 doi: 10.3390/nu15183888
|
| 29 |
Elise Taieb Bimro, Ran Hovav, Abraham Nyska, Tal Assa Glazer, Zecharia Madar. High oleic peanuts improve parameters leading to fatty liver development and change the microbiota in mice intestine. Food & Nutrition Research 2020; 64(0) doi: 10.29219/fnr.v64.4278
|
| 30 |
Georg Peschel, Kilian Weigand, Jonathan Grimm, Martina Müller, Christa Buechler. Serum omentin-1 is correlated with the severity of liver disease in patients with chronic hepatitis C. World Journal of Hepatology 2023; 15(12): 1315-1324 doi: 10.4254/wjh.v15.i12.1315
Abstract(327) |
Core Tip(295) |
Full Article(HTML)(869)
|
Full Article with Cover (PDF)-6085K(59)
|
Full Article (Word)-362K(21)
|
Audio-1515K(7)
|
Peer-Review Report-219K(58)
|
Answering Reviewers-49K(63)
|
Full Article (PDF)-1065K(68)
|
Full Article (XML)-105K(39)
|
Times Cited (1)
|
Total Visits (3424)
|
Open
|
| 31 |
Abdulrahman Ismaiel, Vera Ciornolutchii, Thelva Esposito Herrera, Mohamed Ismaiel, Daniel‐Corneliu Leucuta, Stefan‐Lucian Popa, Dan L. Dumitrascu. Adiponectin as a biomarker in liver cirrhosis—A systematic review and meta‐analysis. European Journal of Clinical Investigation 2024; doi: 10.1111/eci.14328
|
| 32 |
Zara Siu Wa Chui, Yaqian Xue, Aimin Xu. Hormone-based pharmacotherapy for metabolic dysfunction-associated fatty liver disease. Medical Review 2024; 4(2): 158 doi: 10.1515/mr-2024-0007
|